Nautilus Biotechnology (NAUT) files $300M mixed shelf Sep 11, 2026 04:07PM
Leerink Starts Nautilus Biotechnology (NAUT) at Outperform Sep 9, 2026 06:10AM
Nautilus Biotechnology, Inc. (NAUT) Tops Q2 EPS by 4c Jul 28, 2026 06:49AM
Nautilus Biotechnology, Inc. (NAUT) Tops Q1 EPS by 5c Apr 28, 2026 08:00AM
Q1 Virtual Investor Summit Presentations Now Available On Demand Mar 26, 2026 03:46PM


Mar 20, 2026 08:00AM Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26)
Feb 27, 2026 07:12AM Nautilus Biotechnology (NAUT) PT Raised to $4 at Guggenheim
Feb 26, 2026 09:24AM Nautilus Biotechnology, Inc. (NAUT) Tops Q4 EPS by 3c
Oct 28, 2025 08:16AM Nautilus Biotechnology, Inc. (NAUT) Tops Q3 EPS by 4c
Jul 31, 2025 08:36AM Nautilus Biotechnology, Inc. (NAUT) Tops Q2 EPS by 3c
Apr 29, 2025 08:17AM Nautilus Biotechnology, Inc. (NAUT) Tops Q1 EPS by 2c
Feb 28, 2025 07:59AM Nautilus Biotechnology (NAUT) PT Lowered to $2.50 at Guggenheim
Dec 5, 2024 04:14AM Goldman Sachs Downgrades Nautilus Biotechnology (NAUT) to Sell
Oct 29, 2024 08:08AM Nautilus Biotechnology, Inc. (NAUT) Tops Q3 EPS by 4c
Jul 30, 2024 09:23AM Nautilus Biotechnology, Inc. (NAUT) Tops Q2 EPS by 2c
Jun 27, 2024 06:28AM Guggenheim Starts Nautilus Biotechnology (NAUT) at Buy